Literature DB >> 21056498

Pre-operative liver biopsy in cirrhotic patients with early hepatocellular carcinoma represents a safe and accurate diagnostic tool for tumour grading assessment.

Antonio Colecchia1, Eleonora Scaioli, Lucia Montrone, Amanda Vestito, Anna Rita Di Biase, Martina Pieri, Antonia D'Errico-Grigioni, Maria Letizia Bacchi-Reggiani, Matteo Ravaioli, Gian Luca Grazi, Davide Festi.   

Abstract

BACKGROUND & AIMS: Knowledge of pre-operative tumour grade is crucial in the management of hepatocellular carcinoma (HCC) because it can influence recurrence and survival after surgery. The accuracy of pre-operative needle core biopsy (NCB) in tumour grading has been assessed in only a few studies with conflicting results. Our aim was to determine the long-term safety and the overall accuracy of NCB in assessing tumour grading in subjects who had undergone liver resection for a single HCC.
METHODS: Eighty-one cirrhotic patients with HCC who had undergone NCB before liver resection were selected. Only patients with a single HCC and with at least a five-year-follow-up were included. Tumour grading was scored according to a modified Edmondson-Steiner classification: well/moderately (low grade) vs poorly-differentiated (high grade).
RESULTS: In the 81 patients with a solitary HCC (mean size 4.1 ± 2.3cm) tumour grade was correctly identified by NCB in 74 out of 81 (91.4%) HCCs. NCB overall sensitivity and specificity were 65% and 98.1%, respectively, with a PPV of 92% and an NPV of 91%. No major complications (in particular tumour seeding) were observed. The overall survival rates at 1, 3, and 5 years were 83%, 62%, and 44%, respectively; the recurrence rate after a 5-year-follow-up was 56.2% for low grade and 82.3% for high grade tumours (p<0.007).
CONCLUSIONS: Pre-operative NCB can be performed on early (<5 cm) HCC cirrhotic patients because it provides histologically useful information for HCC management with good accuracy and a low complication rate.
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21056498     DOI: 10.1016/j.jhep.2010.06.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  20 in total

1.  From liver cirrhosis to HCC.

Authors:  Luigi Bolondi; Laura Gramantieri
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

Review 2.  Prediction of hepatocellular carcinoma biological behavior in patient selection for liver transplantation.

Authors:  Umberto Cillo; Tommaso Giuliani; Marina Polacco; Luz Maria Herrero Manley; Gino Crivellari; Alessandro Vitale
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 3.  Liver transplantation for hepatocellular carcinoma: an appraisal of current controversies.

Authors:  Yee Lee Cheah; Pierce K H Chow
Journal:  Liver Cancer       Date:  2012-11       Impact factor: 11.740

Review 4.  Prognostic factors for hepatocellular carcinoma recurrence.

Authors:  Antonio Colecchia; Ramona Schiumerini; Alessandro Cucchetti; Matteo Cescon; Martina Taddia; Giovanni Marasco; Davide Festi
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 5.  The role of interventional radiology in the management of hepatocellular carcinoma.

Authors:  N Molla; N AlMenieir; E Simoneau; M Aljiffry; D Valenti; P Metrakos; L M Boucher; M Hassanain
Journal:  Curr Oncol       Date:  2014-06       Impact factor: 3.677

6.  Liver transplantation for hepatocellular carcinoma beyond the Milan criteria.

Authors:  Xiao Xu; Di Lu; Qi Ling; Xuyong Wei; Jian Wu; Lin Zhou; Sheng Yan; Liming Wu; Lei Geng; Qinghong Ke; Feng Gao; Zhenhua Tu; Weilin Wang; Min Zhang; Yan Shen; Haiyang Xie; Wenshi Jiang; Haibo Wang; Shusen Zheng
Journal:  Gut       Date:  2015-03-24       Impact factor: 23.059

7.  Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma.

Authors:  Lijun Wang; Jianguo Wang; Xuanyu Zhang; Jie Li; Xuyong Wei; Jun Cheng; Qi Ling; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  PLoS One       Date:  2015-12-14       Impact factor: 3.240

8.  Rate of seeding with biopsies and ablations of hepatocellular carcinoma: A retrospective cohort study.

Authors:  Jean-Luc Szpakowski; Todd E Drasin; Liisa L Lyon
Journal:  Hepatol Commun       Date:  2017-09-29

9.  A role for CD81 and hepatitis C virus in hepatoma mobility.

Authors:  Claire L Brimacombe; Garrick K Wilson; Stefan G Hübscher; Jane A McKeating; Michelle J Farquhar
Journal:  Viruses       Date:  2014-03-24       Impact factor: 5.048

10.  Liver transplantation for intermediate hepatocellular carcinoma: An adaptive approach.

Authors:  Marco Biolato; Giuseppe Marrone; Luca Miele; Antonio Gasbarrini; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2017-05-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.